Chronic Pain Newswire

Comprehensive Real-Time News Feed for Chronic Pain.

Results 1 - 20 of 279 in Chronic Pain

  1. St. Jude Medical Announces Definitive Agreement to Acquire NeuroThermRead the original story

    1 hr ago | Business Wire

    Acquisition expected to accelerate growth of St. Jude Medical's chronic pain business and strengthen its position as a global leader in developing therapies to treat chronic pain ST.

    Comment?

  2. First-Ever Specialty Center for Management of Chronic Pain Opens in BangaloreRead the original story

    Friday Jul 11 | PressReleasePoint

    ... inaugurated today by the Kannada movie superstar Puneeth Rajkumar. The launch ceremony of the RELIV Center for Chronic Pain Management was chaired by Dr. B.S. Ajai Kumar, Founder Chairman& CEO, HCG Group of Hospitals; playback singer Ms. B.R. Chaya, ...

    Comment?

  3. Top 15 California Cannabis EdiblesRead the original story w/Photo

    Tuesday Jul 8 | High Times

    ... who use cannabis edibles as a replacement for dangerous, addictive pharmaceutical drugs intended to treat chronic pain or insomnia, and these folks require very strong dosage levels, to which they quickly build up a tolerance. This is why brownies ...

    Comment?

  4. Researchers Submit Patent Application, 'Methods, Systems, and Devices ...Read the original story

    Wednesday Jul 9 | Hispanic Business

    ... devices (IMDs). For example, electrical stimulation may be provided for various purposes such as treatment for chronic pain, incontinence, and the like. The IMD is purchased in full from the manufacturer by the patient or an insurer and thereafter ...

    Comment?

  5. Recreational marijuana in Washington: Buyers line up as sales open in VancouverRead the original story w/Photo

    Wednesday Jul 9 | The Oregonian

    ... medical marijuana patient who used to obtain cannabis from Seattle's unregulated dispensaries to treat chronic pain. He said the cost of the commute became too expensive. 9:42 a.m.: Bill Johnson, 70, of Vancouver was downtown Wednesday morning when ...

    Comment?

  6. Opioids: Don't Fix the Blame, Fix the ProblemRead the original story

    Thursday Jul 3 | Pharmaceutical Executive

    ... take charge of the debate on drug safety. In the United States, the use of opioids as first-line treatment for chronic pain conditions doesn't follow either label indications or guideline recommendations. 52% of patients diagnosed with ...

    Comment?

  7. Slim down for the health of it and possibly reduce your hot flashes in the processRead the original story w/Photo

    Monday Jul 7 | Science Daily

    ... such as trouble with - Menopausal women suffer from half as many hot flashes after receiving a non-hormonal chronic pain treatment. The nerve block treatment interrupts the area of the brain that regulates body - Weight loss that occurs in ...

    Comment?

  8. Why Zogenix Inc. Stock TumbledRead the original story

    Tuesday Jul 8 | The Motley Fool

    ... to our investing thesis. ) , a small-cap pharmaceutical company focused on developing therapies to treat chronic pain and central nervous system disorders, tumbled as much as 12% this morning after rival Purdue Pharma's abuse-resistant hydrocodone ...

    Comment?

  9. Why NeuroMetrix (NURO) Stock Is Soaring TodayRead the original story w/Photo

    Tuesday Jul 8 | TheStreet.com

    ... after the FDA cleared the medical device company's wearable technology for over-the-counter use in treating chronic pain. The FDA granted 501(k) clearance for the device, which is in late-stage development. It uses electrical stimulation of sensory ...

    Comment?

  10. FDA Grants Priority Review Designation for Purdue's Once-Daily...Read the original story w/Photo

    Tuesday Jul 8 | Pharmaceutical Processing

    ... 2014. "It is imperative to provide healthcare professionals with an array of therapeutic options to ensure chronic pain patients receive individualized care," said Todd Baumgartner, MD, MPH, Vice President of Regulatory Affairs and Chief Medical ...

    Comment?

  11. FDA approves NeuroMetrix pain deviceRead the original story

    Tuesday Jul 8 | Seeking Alpha

    The FDA grants 510 clearance to NeuroMetrix's Sensus chronic pain treatment device.

    Comment?

  12. FDA Clears NeuroMetrix Wearable Technology for Over-the-Counter Use in Treatment of Chronic PainRead the original story

    Tuesday Jul 8 | Business Wire

    NeuroMetrix, Inc. today announced that its wearable technology for treatment of chronic pain received 510 clearance from the U.S. Food and Drug Administration for over-the-counter use.

    Comment?

  13. FDA To Expedite Review Of Purdue Pharma L.P. Once-Daily Painkiller TabletRead the original story w/Photo

    Tuesday Jul 8 | BioSpace

    ... "It is imperative to provide healthcare professionals with an array of therapeutic options to ensure chronic pain patients receive individualized care," said , MD, MPH, Vice President of Regulatory Affairs and Chief Medical Officer at Purdue Pharma. ...

    Comment?

  14. BioDelivery Sciences shares rise on positive drug trial resultsRead the original story w/Photo

    Monday Jul 7 | News Observer

    BioDelivery Sciences International shares were up nearly 15 percent in early trading Monday after the Raleigh company announced positive Phase 3 clinical trial results for its experimental treatment for chronic pain.

    Comment?

  15. Why BioDelivery Sciences (BDSI) Stock Hit a One-Year High TodayRead the original story w/Photo

    Monday Jul 7 | TheStreet.com

    ... regular opioid therapy. Data from the first late-stage trial in January revealed the drug significantly reduced chronic pain in patients who do not regularly take opioids. BioDelivery and Endo signed an agreement in Jan. 2012 to develop the drug for ...

    Comment?

  16. UPDATE 2-BioDelivery, Endo painkiller moves one step closer to approvalRead the original story

    Monday Jul 7 | Reuters

    ... said on Monday. Data from another late-stage trial in January showed that the drug significantly reduced chronic pain in patients who do not take opioids regularly. Opioid addiction in the United has assumed epidemic proportions but that has not ...

    Comment?

  17. Canadian researchers sound warning on deaths related to use of narcotic painkillersRead the original story w/Photo

    Monday Jul 7 | Canada.com

    "I think that every doctor who contemplates starting a patient on an opioid for chronic pain should ... realize that they are playing with fire," says Dr. David Juurlink, head of clinical pharmacology and toxicology at Sunnybrook Health Sciences Centre.

    Comment?

  18. UPDATE 1-BioDelivery, Endo painkiller effective in studyRead the original story

    Monday Jul 7 | Reuters

    ... late-stage trial. Data from the first late-stage trial in January showed that the drug significantly reduced chronic pain in patients who do not take opioids regularly. Opioids are a class of drugs that includes not only powerful prescription ...

    Comment?

  19. Opioids: Don't Fix the Blame, Fix the ProblemRead the original story

    Thursday Jul 3 | Pharmaceutical Executive

    ... take charge of the debate on drug safety. In the United States, the use of opioids as first-line treatment for chronic pain conditions doesn't follow either label indications or guideline recommendations. 52% of patients diagnosed with ...

    Comment?

  20. Some U.S. States Have More Painkiller Prescriptions Than PeopleRead the original story w/Photo

    Monday Jun 30 | Refinery 29

    ... 100 people; at 138 prescriptions per 100 people, West Virginia's not far behind. At a loss for how to treat chronic pain (and/or badly informed about the dangers of prescription medication), a doctor will often prescribe multiple opiates to a single ...

    Comment?